Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2250c73685b3a24

Jump to content

APLP1

From Wikipedia, the free encyclopedia

APLP1
Identifiers
AliasesAPLP1, APLP, amyloid beta precursor like protein 1
External IDsOMIM: 104775; MGI: 88046; HomoloGene: 68447; GeneCards: APLP1; OMA:APLP1 - orthologs
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_005166
NM_001024807

NM_007467

RefSeq (protein)

NP_001019978
NP_005157

NP_031493

Location (UCSC)Chr 19: 35.87 – 35.88 MbChr 7: 30.13 – 30.14 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Amyloid precursor like protein 1, also known as APLP1, is a protein encoded by the APLP1 gene in humans.[5][6] APLP1 along with APLP2 are important modulators of glucose and insulin homeostasis.[7]

Function

[edit]

This gene encodes a member of the highly conserved amyloid precursor protein gene family. The encoded protein is a membrane-associated glycoprotein that is cleaved by secretases in a manner similar to amyloid beta A4 precursor protein cleavage. This cleavage liberates an intracellular cytoplasmic fragment that may act as a transcriptional activator. The encoded protein may also play a role in synaptic maturation during cortical development. Alternatively spliced transcript variants encoding different isoforms have been described.[5]

APLP1 and APLP2 double knockout mice display hypoglycemia and hyperinsulinemia indicating that these two proteins are important modulators of glucose and insulin homeostasis.[7]

APLP1 has also been implicated in the transmission pathologic α-synuclein in Parkinson's disease[8][9]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000105290 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000006651 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: APLP1 amyloid beta (A4) precursor-like protein 1".
  6. Wasco W, Brook JD, Tanzi RE (January 1993). "The amyloid precursor-like protein (APLP) gene maps to the long arm of human chromosome 19". Genomics. 15 (1): 237–9. doi:10.1006/geno.1993.1047. PMID 8432545.
  7. 1 2 Needham BE, Wlodek ME, Ciccotosto GD, Fam BC, Masters CL, Proietto J, et al. (June 2008). "Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth". J. Pathol. 215 (2): 155–63. doi:10.1002/path.2343. PMID 18393365. S2CID 1064378.
  8. Mao X, Gu H, Kim D, Kimura Y, Wang N, Xu E, et al. (May 2024). "Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein". Nature Communications. 15 (1) 4663. Bibcode:2024NatCo..15.4663M. doi:10.1038/s41467-024-49016-3. PMC 11143359. PMID 38821932.
  9. "New Study Suggests Cancer Drug Could Be Used to Target Protein Connection That Spurs Parkinson's Disease". Johns Hopkins Medicine. 17 June 2024.

Further reading

[edit]
[edit]